dc.creatorMiranda, Izabel Luzia
dc.creatorSantos, Pedro Henrique Costados
dc.creatorKohlhoff, Markus
dc.creatorPurgato, Gislaine Aparecida
dc.creatorDiaz, Marisa Alves Nogueira
dc.creatorMuñoz, Gaspar Diaz
dc.date2022-03-24T18:32:02Z
dc.date2022-03-24T18:32:02Z
dc.date2021
dc.date.accessioned2023-09-26T20:08:15Z
dc.date.available2023-09-26T20:08:15Z
dc.identifierMIRANDA, Izabel Luzia et al. Stereoselective synthesis of (−)‐cytoxazone and its unnatural congener (+)‐5‐epi‐cytoxazone. Chirality, v. 33, n. 8, p. 479-489, 2021. doi.org/10.1002/chir.23334
dc.identifier0899-0042
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/51866
dc.identifier10.1002/chir.23334
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8849424
dc.descriptionAn interesting protocol for stereoselective synthesis of (−)‐cytoxazone and its unnatural stereoisomer (+)‐5‐epi‐cytoxazone from d‐4‐hydroxyphenylglycine in overall yields of 10% and 16%, respectively, is described. The stereoselective addition of cyanide to an N‐Boc protected aminoaldehyde (tert‐butyl ((R)‐1‐(4‐methoxyphenyl)‐2‐oxoethyl)carbamate) (5) constitutes the key step in this approach, producing a mixture of cyanohydrins 6a and b (1,2‐anti and 1,2‐syn tert‐butyl (2‐cyano‐2‐hydroxy‐1‐(4‐methoxyphenyl)ethyl)carbamate) in 89% yield, with reasonable stereoselectivity (1.0:1.8) in favor of the anti‐Felkin product (1,2‐syn). A one‐pot sequence of three successive steps from this mixture produced the oxazolidinone isomers 9a and b ((4R,5R)‐ and (4R,5S)‐4‐(4‐methoxyphenyl)‐2‐oxooxazolidine‐5‐carboxylate). Chromatographic column separation and reduction of the ester function of both precursors led to (−)‐cytoxazone and (+)‐5‐epi‐cytoxazone.
dc.formatapplication/pdf
dc.languageeng
dc.publisherWiley Periodicals
dc.rightsrestricted access
dc.subjectd‐4‐hydroxyphenylglycine
dc.subjectoxazolidinone
dc.subjectstereoisomer
dc.subjectstereoselective addition
dc.titleStereoselective synthesis of (−)‐cytoxazone and its unnatural congener (+)‐5‐epi‐cytoxazone
dc.typeArticle


Este ítem pertenece a la siguiente institución